|
Market Closed -
Euronext Paris
09:25:00 25/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 143.30 EUR | -3.89% |
|
-8.08% | +20.42% |
| 26/09 | US FDA approves Mirum's drug for rare bone disorder | RE |
| 22/09 | European Pharma Leaders Push for National Reforms to Boost Investment | DJ |
| Market Cap | 1.17TCr 1.34TCr 1.11TCr 1.01TCr 1.89TCr 1,28300Cr 1.91TCr 13TCr 5.14TCr 66TCr 5.03TCr 4.92TCr 2,10700Cr | P/E 2026 * |
11.9x | P/E 2027 * | 12.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.04TCr 1.19TCr 983.24Cr 896.04Cr 1.68TCr 1,13700Cr 1.69TCr 12TCr 4.56TCr 58TCr 4.45TCr 4.36TCr 1,86700Cr | EV / Sales 2026 * |
2.28x | EV / Sales 2027 * | 2.03x |
| Free-Float |
40.65% | Yield 2026 * |
1.07% | Yield 2027 * | 1.07% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| IPN | Real-time | |
CBOE
| IPNp | Real-time | |
|
London S.E.
| 0MH6 | Delayed | |
|
Mexican S.E.
| IPN N | End-of-day quote | |
|
CBOE
| 0MH6 | Real-time | |
|
Tradegate
| I7G | Real-time | |
|
Deutsche Boerse AG
| I7G | Delayed | |
|
Börse Stuttgart
| I7G | Delayed | |
|
Boerse Muenchen
| I7G | Real-time | |
|
Wiener Boerse
| IPN | End-of-day quote |
Last Transcript: Ipsen
| 1 day | -3.89% | ||
| 1 week | -8.08% | ||
| Current month | -12.14% | ||
| 1 month | -13.67% | ||
| 3 months | -11.65% | ||
| 6 months | -5.66% | ||
| Current year | +20.42% |
| 1 week | 141.1 |  | 151.3 |
| 1 month | 141.1 | | 170.9 |
| Current year | 116 | | 174 |
| 1 year | 111.6 | | 174 |
| 3 years | 87.95 | | 174 |
| 5 years | 77 | | 174 |
| 10 years | 34.2 | | 174 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Loew
CEO | Chief Executive Officer | 59 | 01/07/2020 |
| Chief Executive Officer | 57 | 01/01/2020 | |
Pierrick Lefranc
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Antoine Flochel
BRD | Director/Board Member | 61 | 30/08/2005 |
| Chairman | 68 | 22/11/2010 | |
Carol Xueref
BRD | Director/Board Member | 69 | 01/06/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/09/26 | Buy | Director | 500 | 0.0006% | ||
| 03/09/26 | Sell | Director | -1,000 | 0.0012% | ||
| 24/08/26 | Sell | Chairman | -3,840 | 0.0046% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.89% | -8.08% | +28.52% | +17.08% | 1.34TCr | |
| +0.13% | +2.65% | +65.61% | +114.28% | 1,05500Cr | |
| +0.20% | +0.46% | +52.60% | +69.24% | 65TCr | |
| -0.29% | +0.14% | +20.96% | +70.93% | 47TCr | |
| -0.85% | +0.98% | +41.29% | +44.38% | 35TCr | |
| +0.71% | +4.08% | +22.24% | +29.51% | 27TCr | |
| +1.23% | +0.42% | +14.57% | +12.13% | 26TCr | |
| +2.11% | +7.51% | +52.89% | +55.37% | 22TCr | |
| +0.83% | +0.55% | +35.99% | +101.70% | 19TCr | |
| 0.00% | -10.14% | -29.94% | -60.30% | 17TCr | |
| Average | -0.07% | -0.14% | +30.47% | +45.43% | 36.52TCr | |
| Weighted average by Cap. | +0.01% | +1.28% | +41.49% | +67.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 456.37Cr 520.08Cr 431.02Cr 392.8Cr 735.3Cr 50TCr 740.54Cr 5.16TCr 2TCr 25TCr 1.95TCr 1.91TCr 82TCr | 465.33Cr 530.29Cr 439.49Cr 400.51Cr 749.73Cr 51TCr 755.08Cr 5.26TCr 2.04TCr 26TCr 1.99TCr 1.95TCr 83TCr |
| Net income | 101.06Cr 115.17Cr 95Cr 87Cr 162.83Cr 11TCr 163.99Cr 1.14TCr 442.39Cr 5.64TCr 432.41Cr 423.06Cr 18TCr | 98Cr 111.88Cr 93Cr 84Cr 158.18Cr 11TCr 159.31Cr 1.11TCr 429.76Cr 5.48TCr 420.07Cr 410.98Cr 18TCr |
| Net Debt | -133.85Cr -152.54Cr -126.42Cr -115.21Cr -215.66Cr -15TCr -217.2Cr -1.51TCr -585.94Cr -7.47TCr -572.73Cr -560.34Cr -24TCr | -229.57Cr -261.62Cr -216.82Cr -197.59Cr -369.88Cr -25TCr -372.52Cr -2.59TCr -1TCr -13TCr -982.29Cr -961.04Cr -41TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/26/25 | €143.30 | -3.89% | 1,19,496 |
| 24/26/24 | €149.10 | +0.68% | 1,27,956 |
| 23/26/23 | €148.10 | -1.66% | 75,866 |
| 22/26/22 | €150.60 | +1.83% | 1,08,330 |
| 21/26/21 | €147.90 | -5.13% | 2,38,553 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IPN Stock
Select your edition
All financial news and data tailored to specific country editions
